ASND Ascendis Pharma A
Biotechnology NasdaqGS
Trading Signals (ASND)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $154.69
- Medium Support $161.29
- Weak Support $167.88
Resistance Levels
- Weak Resistance $181.08
- Medium Resistance $187.67
- Strong Resistance $194.27
Stop Loss Suggestions
- Conservative $161.41
- Moderate $164.59
- Aggressive $157.99
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Short & Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (ASND)
Quarterly Outlook :
2025-09-14
Bullish Scenario
from current 12.43%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
2025-09-14
Base Scenario
from current -1.55%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
2025-09-14
Bearish Scenario
from current -12.43%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
Annual Outlook
2025-09-14
Bullish Scenario
from current 24.85%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
2025-09-14
Base Scenario
from current -3.11%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
2025-09-14
Bearish Scenario
from current -24.85%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (13.48) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (60.03) is in bullish territory, indicating upward momentum. MACD line (5.47) is below Signal line (6.23) (bearish crossover), confirming downward momentum. Current Weekly ATR is 10.84, indicating the average weekly price range.
Technical Analysis (ASND)
Trend Identification
EMA
Exponential Moving Average
Current price (174.48) is above both Short MA (171.26) and Long MA (168.78). This indicates strong bullish momentum. Short MA (171.26) is above Long MA (168.78), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. All MAs are in bullish order (Price > Short MA > Long MA > Very Long MA 164.29). This is a strong bullish alignment. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.0700) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). A bullish crossover below the zero line can indicate a reversal from a prior downtrend. Consider this as a potential early buy signal.
ADX
Average Directional Index
ADX (13.88) indicates a weak or non-existent trend (ranging market). +DI (21.79) is above -DI (15.48), suggesting a bullish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2025-09-14)
Relative Strength Index
RSI (55.63) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2025-09-14)
On-Balance Volume
OBV (1702374.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-09-14)
Stochastic Oscillator
Stochastics (%K: 65.29, %D: 42.46) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed. This indicates upward momentum. Be cautious if it's already in the overbought region.
CCI (2025-09-14)
Commodity Channel Index
CCI (88.63) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2025-09-14)
Average True Range
Current ATR is 6.5300. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-09-14)
Volatility Bands
Current price (174.48) is within the Bollinger Bands (162.44 - 180.08). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (171.26), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (ASND)
SAR (2025-09-14)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 161.41 is 7.49% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-09-14)
Neutral
Stochastic is in neutral territory (65.3). No clear overbought/oversold signal. Current crossover status: Bullish.
RSI (2025-09-14)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-09-14)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the upper half of the bands, suggesting a bullish bias.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (ASND)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| RA Capital Management, L.P. | INSTITUTIONAL | 10281496 | 17.1% | 2025-03-31 |
| Westfield Capital Management Co LP | INSTITUTIONAL | 5479259 | 9.11% | 2025-03-31 |
| Avoro Capital Advisors LLC | INSTITUTIONAL | 5218000 | 8.68% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 4672943 | 7.77% | 2025-03-31 |
| Janus Henderson Group PLC | INSTITUTIONAL | 4486949 | 7.46% | 2025-03-31 |
| Artisan Partners Limited Partnership | INSTITUTIONAL | 4256627 | 7.08% | 2025-03-31 |
| T. Rowe Price Investment Management, Inc. | INSTITUTIONAL | 3053824 | 5.08% | 2025-03-31 |
| Capital International Investors | INSTITUTIONAL | 2874792 | 4.78% | 2025-03-31 |
| Price (T.Rowe) Associates Inc | INSTITUTIONAL | 2256102 | 3.75% | 2025-03-31 |
| Morgan Stanley | INSTITUTIONAL | 1903531 | 3.17% | 2025-03-31 |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | MUTUALFUND | 1304613 | 2.17% | 2025-02-28 |
| GROWTH FUND OF AMERICA | MUTUALFUND | 1062134 | 1.77% | 2025-03-31 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | MUTUALFUND | 1020000 | 1.7% | 2025-03-31 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | MUTUALFUND | 976876 | 1.62% | 2025-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | MUTUALFUND | 948311 | 1.58% | 2025-03-31 |
| Artisan Partners Funds Inc.-Artisan Mid Cap Fund | MUTUALFUND | 938852 | 1.56% | 2025-03-31 |
| Fidelity Select Portfolios-Health Care Portfolio | MUTUALFUND | 750000 | 1.25% | 2025-04-30 |
| T. Rowe Price New Horizons Fund, Inc. | MUTUALFUND | 634821 | 1.06% | 2025-03-31 |
| Columbia Fd.s Varbl Series TRT II-CTIVP - Westfield Select Large Cap G | MUTUALFUND | 631977 | 1.05% | 2025-03-31 |
| Fidelity Select Portfolios-Biotechnology Portfolio | MUTUALFUND | 631809 | 1.05% | 2025-04-30 |